NASDAQ: VRDN - Viridian Therapeutics, Inc.

Yield per half year: +56.7%
Sector: Healthcare

Share chart Viridian Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Viridian Therapeutics, Inc., биотехнологическая компания, открывает и разрабатывает методы лечения серьезных и редких заболеваний. Ассортимент продукции компании включает VRDN-001, моноклональное антитело, нацеленное на рецептор инсулиноподобного фактора роста-1, которое находится на стадии 3 клинических испытаний для лечения заболеваний глаз, связанных с щитовидной железой (TED); и VRDN-002 и VRDN-003, гуманизированные моноклональные антитела IGF-1R следующего поколения, нацеленные на IGF-1R и включающие технологию продления периода полувыведения для лечения TED.

More details
Он также предоставляет VRDN-004, программу разработки терапевтических антител для лечения редких заболеваний; и VRDN-005 и VRDN-006, доклиническая программа для аутоиммунных заболеваний. Ранее компания называлась Miragen Therapeutics, Inc., а в январе 2021 года сменила название на Viridian Therapeutics, Inc. Штаб-квартира Viridian Therapeutics, Inc. находится в Уолтеме, штат Массачусетс.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Выручка 0.0045
EBITDA -0.041
P/S 3.75
EV/EBITDA -0.0047
Цена ао 14.34
P/BV 1.06
Сайт https://www.viridiantherapeutics.com
ISIN US92790C1045
Число акций ао 0.04476 млрд
Валюта usd
IPO date 2014-06-18
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: 0% (23.63)
Change price per week: +1.59% (23.26)
Change price per month: +7.12% (22.06)
Change price per 3 month: +47.96% (15.97)
Change price per half year: +56.7% (15.08)
Change price per year: +91.49% (12.34)
Change price per 3 year: +34.87% (17.52)
Change price per 5 year: +2 129.25% (1.06)
Change price per year to date: +55.26% (15.22)
All parameters

Underestimation

Title Value Grade
P/S 3201.3 1
P/BV 2.27 6
P/E 0 0
EV/EBITDA -3.92 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -48.48 0
ROE, % -53.78 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0894 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % -92.96 0
Yield Ebitda, % 473.53 10
Yield EPS, % -73.31 0
Total: 6
More

ETF Share, % Profitability for 1 year, % Dividends, %
Avantis U.S Small Cap Equity ETF 0.0352 27.774101036841 1.68271
Virtus LifeSci Biotech Clinical Trials ETF 1.34343 63.040315712071 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.073 24.74842126706 1.59225
Dimensional US Core Equity Market ETF 0.00032 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00017 31.530984204131 1.3557
iShares ESG Aware MSCI USA Small-Cap ETF 0.06832 33.616398243045 1.49366
Fidelity MSCI Health Care Index ETF 0.01529 13.390080209527 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.0311 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.00804 5.9237999659878 1.47892
Humankind US Stock ETF 0.00612 18.809430395549 1.99919
iShares Morningstar Small-Cap ETF 0.02408 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02443 33.628071953382 0.72598
iShares Morningstar Small Cap Value ETF 0.02346 26.701717953559 2.50476
iShares Micro-Cap ETF 0.35381 36.318555985322 1.54048
iShares Russell 2000 Growth ETF 0.07584 38.042556988 0.6026
iShares Russell 3000 ETF 0.00288 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.02408 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02443 680.05582339508 0.72598
iShares Morningstar Small-Cap Value ETF 0.02346 227.12514109528 2.50476
Direxion Daily S&P Biotech Bull 3x Shares 0.25726 4067.9190751445 0.25924
Nuveen ESG Small-Cap ETF 0.09651 29.971671388102 1.41019
Schwab U.S. Small-Cap ETF 0.0342 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00214 32.5 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00415 23.600605143722 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.01483 32.205226109465 1.69572
ProShares UltraPro Russell2000 0.03016 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.05 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0.03 35.648084105685 1.48801



Head Job title Payment Year of birth
Dr. Eric N. Olson Ph.D. Co-Founder & Chairman of Scientific Advisory Board N/A
Dr. Michael R. Bristow M.D., Ph.D. Co-Founder & Member of the Scientific Advisory Board N/A 1945 (79 years)
Dr. Marvin H. Caruthers Ph.D. Co-Founder & Scientific Advisory Board Member N/A 1940 (84 years)
Mr. Vahe Bedian Ph.D. Co-Founder & Scientific Advisor N/A
Mr. Stephen F. Mahoney J.D., MBA CEO, President & Director N/A 1971 (53 years)
Mr. Seth Harmon Senior VP of Finance and Accounting, Principal Financial & Accounting Officer N/A 1980 (44 years)
Mr. Thomas W. Beetham J.D., MBA Chief Operating Officer N/A 1970 (54 years)
Mr. John A. Jordan Vice President of Investor Relations & Corporate Communications N/A
Ms. Jennifer Tousignant J.D. Chief Legal Officer N/A 1972 (52 years)
Ms. Melissa Manno Chief Human Resources Officer

Address: United States, Waltham. MA, 221 Crescent Street - open in Google maps, open in Yandex maps
Website: https://www.viridiantherapeutics.com